| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |